Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Invest New Drugs. 2010 Jan 15;29(3):473–480. doi: 10.1007/s10637-009-9381-y

Table 1.

Patient characteristics

Cohort A (n=12) Cohort B (n=7) Cohort C (n=11) Cohort D (n=6) Cohort E (n=3) Total (n=39)
Age
 Median 51.0 59.0 63.0 64.5 48.0 56.0
 Range (25.0–74.0) (46.0–78.0) (38.0–76.0) (28.0–80.0) (35.0–56.0) (25.0–80.0)
Gender
 Female 9 3 8 3 2 25
 Male 3 4 3 3 1 14
Performance score
 0 6 4 4 3 1 18
 1 6 3 7 3 2 21
Prior chemotherapy
 Yes 12 7 10 6 3 38
Prior surgery
 Yes 12 7 11 6 3 39
Prior radiation
 Yes 5 4 5 2 1 17
 No 7 3 6 4 2 22
Primary site
 Ovarian 3 2 0 1 1 7
 Lung 3 1 1 0 0 5
 Other 6 4 10 5 2 27